CSIR Biosciences conducts life sciences research that has significant impact on how drugs are identified in the medical and pharmaceutical industry. The unit’s offerings in translational biomedical research are an invaluable resource for clinicians, researchers and pharmaceutical companies.

The unit’s competency in translational biomedical research brings together systems biology and synthetic biology to support precision medicine in a clinical environment. Expertise includes phenotypic screens across many genotypes – drug sensitivity, precision medicine, high-content imaging, pre-clinical assays across a broad spectrum of genetic variants and stratify disease and genetic variants and link to therapeutic options.